Concepedia

Ratiometric real-time monitoring of hydroxyapatite–doxorubicin nanotheranostic agents for on-demand tumor targeted chemotherapy

Yao Kang, Wen Sun, Jiangli Fan, Zimu Wei, Suzhen Wang, Mingle Li, Zhen Zhang, Yahui Xie, Jianjun Du, Xiaojun Peng

Materials Chemistry Frontiers · 2018 · 15 citations · 43 references

DOI

Concepts

Abstract

Hydroxyapatite–doxorubicin nanotheranostic agents are used for tumor-targeted chemotherapy, providing a platform for ratiometric real-time tracking of drug release.

References

43

Cancer statistics, 2016

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2016 · 16.2K citations · Full text

, , +16

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

Walter Stummer, Uwe Pichlmeier, Thomas R. Meinel et al. · The Lancet Oncology · 2006 · 3.4K citations

, , +15

Cancer biomarker detection: recent achievements and challenges

Li Wu, Xiaogang Qu · Chemical Society Reviews · 2015 · 1.2K citations

, , +16

Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug–Drug Conjugate for Cancer Therapy

Ping Huang, Dali Wang, Yue Su et al. · Journal of the American Chemical Society · 2014 · 716 citations

, , +17

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

P. Vasey, Stan B. Kaye, Rachel Morrison et al. · PubMed · 1999 · 691 citations

, , +16